Please login to the form below

Not currently logged in
Email:
Password:

Type 2 diabetes market set to soar to $64bn by 2026

Rising prevalence, progressive nature and diagnosis of the condition behind the surge

money

The type 2 diabetes market is set to surge, rising from $28.6bn in 2016 to an estimated $64bn in 2026.

The seven major markets of the US, France, Germany, Italy, Spain, UK and Japan are expected to see 8.4% compound annual growth, driven by the condition’s rising prevalence, progressive nature and diagnosis.

The rise in disease-related comorbidities will also play a part in the projected market boost as more patients require multiple drug therapies, according to research and analysis group GlobalData.

Managing healthcare analyst Jesus Cuaron said: “All currently available treatments for type 2 diabetes are initially effective and reduce complication rates, but they lack the ability to maintain glycaemic control in the long term because of the progressive nature of pancreatic B-cell dysfunction.

“This represents one of the highest unmet needs in the type 2 diabetes space and demonstrates that the market has a significant growth opportunity for new patent-protected products that successfully address underlying disease pathology, cardiovascular concerns or compliance issues.”

Article by
Gemma Jones

17th August 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....